Literature DB >> 12162875

Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines.

Hélène Gary-Gouy1, Pierre Lebon, Ali H Dalloul.   

Abstract

The principal interferon-alpha/beta (IFN-I)-producing cells are plasmacytoid dendritic cell (PDC) precursors belonging to the lymphoid lineage. Monocytes that can differentiate into dendritic cells (DC) also produce IFN-I, although much less than PDC, after interaction with infectious agents. We show that whereas viruses trigger these cells to produce IFN-I, the amount of IFN is tightly controlled by cytokines. Monocytes produced IFN-I in response to Sendai virus (SV) infection, and PDC responded to both SV and herpes simplex virus (HSV). All cytokines tested failed to induce production of IFN-I in the absence of infection. However, among 18 relevant cytokines, incubation of PDC with interleukin-4 (IL-4), IL-15, and IL-7 alone or in combination with IL-3 before infection, enhanced IFN-I secretion. At variance, IL-12 alone or in synergy with granulocyte-macrophage colony-stimulating factor (GM-CSF) was active on SV-infected but not on HSV-infected monocytes. Tumor necrosis factor-alpha (TNF-alpha) and IL-4 inhibited IFN-I production by PDC and monocytes, respectively, and IL-10 strongly inhibited IFN-I production in both cell lineages. The response of PDC to IL-7 and IL-15, which also activate natural killer (NK) cell maturation, further emphasizes the cooperation between these two cell subsets in the control of innate immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162875     DOI: 10.1089/10799900260100132

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  33 in total

Review 1.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Impairment of IFN-alpha production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma.

Authors:  Kazuko Uno; Yoshiki Suginoshita; Kazuhiro Kakimi; Fuminori Moriyasu; Mayumi Hirosaki; Taro Shirakawa; Tsunataro Kishida
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.

Authors:  Clio P Mavragani; Timothy B Niewold; Niki M Moutsopoulos; Stanley R Pillemer; Sharon M Wahl; Mary K Crow
Journal:  Arthritis Rheum       Date:  2007-12

Review 4.  Periodontal disease immunology: 'double indemnity' in protecting the host.

Authors:  Jeffrey L Ebersole; Dolphus R Dawson; Lorri A Morford; Rebecca Peyyala; Craig S Miller; Octavio A Gonzaléz
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

5.  RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2.

Authors:  Daniel J J Carr; Lisa Tomanek; Robert H Silverman; Iain L Campbell; Bryan R G Williams
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.

Authors:  Jessica R Spengler; Kerry J Lavender; Cynthia Martellaro; Aaron Carmody; Andreas Kurth; James G Keck; Greg Saturday; Dana P Scott; Stuart T Nichol; Kim J Hasenkrug; Christina F Spiropoulou; Heinz Feldmann; Joseph Prescott
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

7.  Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.

Authors:  Elina I Zuniga; Li-Ying Liou; Lauren Mack; Marilyn Mendoza; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

8.  Hepatitis C virus modulates human monocyte-derived dendritic cells.

Authors:  E A Eksioglu; J R Bess; H Zhu; Y Xu; H-J Dong; J Elyar; D R Nelson; C Liu
Journal:  J Viral Hepat       Date:  2010-11       Impact factor: 3.728

9.  Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab.

Authors:  Christophe Richez; Thierry Schaeverbeke; Chantal Dumoulin; Joël Dehais; Jean-François Moreau; Patrick Blanco
Journal:  Arthritis Res Ther       Date:  2009-06-29       Impact factor: 5.156

10.  Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells.

Authors:  Maria Carlan Silva; Antonieta Guerrero-Plata; Felicia D Gilfoy; Roberto P Garofalo; Peter W Mason
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.